Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis.

Article Details

Citation

Cruz MP

Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis.

P T. 2018 Jan;43(1):25-28.

PubMed ID
29290672 [ View in PubMed
]
Abstract

Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis.

DrugBank Data that Cites this Article

Drugs